Literature DB >> 16723615

Transmission of lymphocytic choriomeningitis virus by organ transplantation.

Staci A Fischer1, Mary Beth Graham, Matthew J Kuehnert, Camille N Kotton, Arjun Srinivasan, Francisco M Marty, James A Comer, Jeannette Guarner, Christopher D Paddock, Dawn L DeMeo, Wun-Ju Shieh, Bobbie R Erickson, Utpala Bandy, Alfred DeMaria, Jeffrey P Davis, Francis L Delmonico, Boris Pavlin, Anna Likos, Martin J Vincent, Tara K Sealy, Cynthia S Goldsmith, Daniel B Jernigan, Pierre E Rollin, Michelle M Packard, Mitesh Patel, Courtney Rowland, Rita F Helfand, Stuart T Nichol, Jay A Fishman, Thomas Ksiazek, Sherif R Zaki.   

Abstract

BACKGROUND: In December 2003 and April 2005, signs and symptoms suggestive of infection developed in two groups of recipients of solid-organ transplants. Each cluster was investigated because diagnostic evaluations were unrevealing, and in each a common donor was recognized.
METHODS: We examined clinical specimens from the two donors and eight recipients, using viral culture, electron microscopy, serologic testing, molecular analysis, and histopathological examination with immunohistochemical staining to identify a cause. Epidemiologic investigations, including interviews, environmental assessments, and medical-record reviews, were performed to characterize clinical courses and to determine the cause of the illnesses.
RESULTS: Laboratory testing revealed lymphocytic choriomeningitis virus (LCMV) in all the recipients, with a single, unique strain of LCMV identified in each cluster. In both investigations, LCMV could not be detected in the organ donor. In the 2005 cluster, the donor had had contact in her home with a pet hamster infected with an LCMV strain identical to that detected in the organ recipients; no source of LCMV infection was found in the 2003 cluster. The transplant recipients had abdominal pain, altered mental status, thrombocytopenia, elevated aminotransferase levels, coagulopathy, graft dysfunction, and either fever or leukocytosis within three weeks after transplantation. Diarrhea, peri-incisional rash, renal failure, and seizures were variably present. Seven of the eight recipients died, 9 to 76 days after transplantation. One recipient, who received ribavirin and reduced levels of immunosuppressive therapy, survived.
CONCLUSIONS: We document two clusters of LCMV infection transmitted through organ transplantation. Copyright 2006 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2006        PMID: 16723615     DOI: 10.1056/NEJMoa053240

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  168 in total

1.  X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation.

Authors:  Sébastien Igonet; Marie-Christine Vaney; Clemens Vonrhein; Clemens Vonhrein; Gérard Bricogne; Enrico A Stura; Hans Hengartner; Bruno Eschli; Félix A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus.

Authors:  Jana Tomaskova; Ingrid Oveckova; Martina Labudova; Lubomira Lukacikova; Katarina Laposova; Juraj Kopacek; Silvia Pastorekova; Jaromir Pastorek
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 3.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

Review 4.  [Specific infections in organ transplantation].

Authors:  M Cornberg; B Schlevogt; J Rademacher; A Schwarz; M Sandherr; G Maschmeyer
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

5.  Serological survey of rodent-borne viruses in Finnish field voles.

Authors:  Kristian M Forbes; Liina Voutilainen; Anne Jääskeläinen; Tarja Sironen; Paula M Kinnunen; Peter Stuart; Olli Vapalahti; Heikki Henttonen; Otso Huitu
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

6.  Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.

Authors:  Lukas Flatz; Cheng Cheng; Lingshu Wang; Kathryn E Foulds; Sung-Youl Ko; Wing-Pui Kong; Rahul Roychoudhuri; Wei Shi; Saran Bao; John-Paul Todd; Mohammed Asmal; Ling Shen; Mitzi Donaldson; Stephen D Schmidt; Jason G D Gall; Daniel D Pinschewer; Norman L Letvin; Srinivas Rao; John R Mascola; Mario Roederer; Gary J Nabel
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 7.  Novel approaches in anti-arenaviral drug development.

Authors:  Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal:  Virology       Date:  2010-12-22       Impact factor: 3.616

8.  Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Authors:  Melissa W Hayes; Ricardo Carrion; Jerritt Nunneley; Andrei E Medvedev; Maria S Salvato; Igor S Lukashevich
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 9.  [Infections as causes of fever of unknown origin].

Authors:  A Schneidewind; B Ehrenstein; B Salzberger
Journal:  Internist (Berl)       Date:  2009-06       Impact factor: 0.743

10.  Receptor use by the Whitewater Arroyo virus glycoprotein.

Authors:  Therese Reignier; Jill Oldenburg; Meg L Flanagan; Genevieve A Hamilton; Vanessa K Martin; Paula M Cannon
Journal:  Virology       Date:  2007-11-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.